When confronted with an infected ingrown hair, the first rule is not to lance the lesion to extract the pus.
This manipulation, often performed with the fingers or a non-sterile object, favours the introduction of additional bacteria into the already infected hair follicle. It can thus aggravate the local inflammation, prolong the infection and increase the risk of complications, such as the formation of furuncles, which correspond to a deep infection of the pilosebaceous follicle.
Care is primarily based on appropriate hygiene measures. It is recommended to gently cleanse the affected area once or twice daily with lukewarm water and a mild cleanser to limit bacterial proliferation without further compromising the skin barrier. Daily application of a topical antiseptic may also be considered to reduce the bacterial load.
In certain marked inflammatory cases, the healthcare professional may also recommend a steroid cream for ingrown hairs to reduce inflammation and perifollicular oedema. It is also essential to suspend any form of hair removal or shaving on the affected area until the lesions have completely resolved, to prevent sustaining inflammation and the development of new follicular infections.
In the majority of cases, the infection associated with an ingrown hair remains superficial and transient, resolving within a few days. However, if the lesions become very painful, spread, are accompanied by systemic signs or evolve into an abscess, a dermatological consultation is required. Depending on the severity, the physician may prescribe topical or oral antibiotics to control the bacterial infection. Other local approaches may also be offered, such as benzoyl peroxide, which has antibacterial properties, or retinoids topical, which help to normalise follicular keratinisation and reduce recurrences.
In certain cases, alternative therapeutic approaches may be considered. When infected ingrown hairs result in persistent pigmented spots, particularly in darker skin phototypes, the dermatologist may recommend using depigmenting agents such as hydroquinone. This agent works by inhibiting tyrosinase, a key enzyme in the melanin synthesis process, and enables the gradual reduction of post-inflammatory hyperpigmentation.
In patients with infected ingrown hairs that are frequent and resistant to conventional measures, particularly in the context of Pseudofolliculitis barbae, laser therapy constitutes an appealing long-term option. By targeting the hair follicle and reducing hair density and stiffness, the laser reduces the risk of subcutaneous regrowth and, consequently, the associated inflammatory and infectious phenomena.
Furthermore, particularly in women, the use of topical eflornithine may also be considered. This molecule inhibits ornithine decarboxylase, an enzyme involved in hair growth, thereby slowing the rate of hair regrowth. By reducing the frequency of shaving or epilation, it indirectly helps to minimise the occurrence of ingrown hairs and related follicular infections.
Finally, when infected ingrown hairs occur in the context of excessive or unusual hair growth, an endocrinological consultation may be appropriate. A hormonal imbalance, particularly hyperandrogenism, can promote dense, coarse hair, mechanically increasing the risk of ingrown hairs and chronic folliculitis.